↓ Skip to main content

Early interim 18F-FDG PET in Hodgkin’s lymphoma: evaluation on 304 patients

Overview of attention for article published in European Journal of Nuclear Medicine and Molecular Imaging, September 2011
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
110 Dimensions

Readers on

mendeley
42 Mendeley
Title
Early interim 18F-FDG PET in Hodgkin’s lymphoma: evaluation on 304 patients
Published in
European Journal of Nuclear Medicine and Molecular Imaging, September 2011
DOI 10.1007/s00259-011-1916-8
Pubmed ID
Authors

Pier Luigi Zinzani, Luigi Rigacci, Vittorio Stefoni, Alessandro Broccoli, Benedetta Puccini, Antonio Castagnoli, Luca Vaggelli, Lucia Zanoni, Lisa Argnani, Michele Baccarani, Stefano Fanti

Abstract

The use of early (interim) PET restaging during first-line therapy of Hodgkin's lymphoma (HL) in clinical practice has considerably increased because of its ability to provide early recognition of treatment failure allowing patients to be transferred to more intensive treatment regimens.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 42 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 42 100%

Demographic breakdown

Readers by professional status Count As %
Student > Postgraduate 8 19%
Student > Doctoral Student 5 12%
Professor 4 10%
Other 4 10%
Researcher 4 10%
Other 7 17%
Unknown 10 24%
Readers by discipline Count As %
Medicine and Dentistry 26 62%
Biochemistry, Genetics and Molecular Biology 2 5%
Agricultural and Biological Sciences 1 2%
Energy 1 2%
Physics and Astronomy 1 2%
Other 0 0%
Unknown 11 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 March 2012.
All research outputs
#19,214,418
of 23,806,312 outputs
Outputs from European Journal of Nuclear Medicine and Molecular Imaging
#2,305
of 3,083 outputs
Outputs of similar age
#105,857
of 127,536 outputs
Outputs of similar age from European Journal of Nuclear Medicine and Molecular Imaging
#15
of 19 outputs
Altmetric has tracked 23,806,312 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,083 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.1. This one is in the 15th percentile – i.e., 15% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 127,536 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 8th percentile – i.e., 8% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 19 others from the same source and published within six weeks on either side of this one. This one is in the 15th percentile – i.e., 15% of its contemporaries scored the same or lower than it.